Q2 2026 Holdings
Filed 2026-08-14 | 27 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $179.5M | 1,841,667 | 16.1% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $138.8M | 2,950,000 | 12.5% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $132.3M | 993,000 | 11.9% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $90.9M | 2,350,000 | 8.2% |
| Alumis Inc(ALMS) | COM | 022307102 | $79.7M | 2,830,700 | 7.2% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $68.5M | 1,971,054 | 6.2% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $66.0M | 9,693,244 | 5.9% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $42.8M | 1,748,000 | 3.9% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $39.7M | 338,900 | 3.6% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $35.5M | 310,000 | 3.2% |
| Aktis Oncology Inc(AKTS) | COM | 01021M104 | $31.0M | 960,847 | 2.8% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $29.6M | 490,000 | 2.7% |
| Erasca IncCall | CALL | 29479A908 | $23.0M | 1,255,000 | 2.1% |
| Palisade BIO Inc(PALI) | COM | 696389402 | $21.5M | 10,276,317 | 1.9% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $20.4M | 2,075,000 | 1.8% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $19.7M | 270,000 | 1.8% |
| Summit Therapeutics Inc(SMMT) | COM | 86627T108 | $18.2M | 1,250,000 | 1.6% |
| Pharvaris N V(PHVS) | COM | N69605108 | $15.8M | 456,721 | 1.4% |
| Adlai Nortye LTD(ANL) | SPONSORED ADS | 00704R109 | $10.7M | 934,716 | 1.0% |
| Precision Biosciences Inc(DTIL) | COM NEW | 74019P207 | $10.6M | 1,350,000 | 1.0% |
| DBV Technologies S A(DBVT) | SPONSORED ADS | 23306J309 | $9.4M | 574,200 | 0.8% |
| Faeth Therapeutics Inc(SNSE) | COM NEW | 81728A207 | $9.0M | 361,010 | 0.8% |
| Gyre Therapeutics Inc(GYRE) | COM | 403783103 | $6.3M | 954,416 | 0.6% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $5.9M | 315,000 | 0.5% |
| Unicycive Therapeutics Inc(UNCY) | COM NEW | 90466Y202 | $4.7M | 1,000,000 | 0.4% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $1.7M | 3,050,000 | 0.2% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $1.3M | 7,750,000 | 0.1% |